Based on the findings of the present study, we conclude that anti-SMP antibodies are exclusively present in sera from SLE patients and that the new anti-SMP ELISA test appears to offer a new serological reagent that will improve our ability to diagnosis SLE and to discriminate SLE from other autoimmune and infectious diseases. Here, FAM53B is linked to systemic lupus erythematosus.